Investing.com-- U.S. President Donald Trump on Monday nominated economist E.J. Antoni as the next commissioner of the Bureau ...

The U.S. and Russia agreed to hold a summit on August 15, with President Donald Trump set to meet Russian counterpart ...

JPMorgan (NYSE: JPM) told investors in a note Monday that Eli Lilly & Co. (NYSE: LLY) shares are its “top pick” among U.S.

For the third quarter, Ralliant forecasts revenue between $513 million and $527 million, above the analyst consensus of $501.6 million. The company also expects adjusted earnings per share of $0.54 to ...

For the full year 2025, Microvast maintained its revenue guidance of $450 million to $475 million, representing growth of 18% to 25% YoY. The company also updated its targeted gross margin from 30% to ...

Investing.com -- Yalla Group Limited (NYSE: YALA ), the largest social networking and gaming company in the Middle East and North Africa region, reported second-quarter revenue that fell short of ...

Mercury Systems (NASDAQ: MRCY) rose 7% after quarterly results topped estimates. Mercury Systems reported Q4 EPS of $0.47, $0.25 better than the analyst estimate of $0.22. Revenue for the quarter came ...

The company reported a net loss of $34.4 million for the quarter, compared to net income of $3.7 million in Q2 2024. This decline was primarily attributed to a $57.2 million increase in foreign ...

OVERLAND PARK, Kan. - Compass Minerals (NYSE: CMP) reported better-than-expected revenue for its fiscal 2025 third quarter, though earnings fell short of analyst expectations. The essential minerals ...

Investing.com -- BigBear.ai Holdings, Inc. (NYSE: BBAI) shares tumbled 21.6% after the AI-powered decision intelligence solutions provider reported second-quarter results that missed analyst ...

The urban air mobility company’s shares fell 1.6% following the earnings release as investors reacted to the earnings miss. The company reported an adjusted EBITDA loss of $118.7 million for the ...

Investing.com -- Septerna, Inc. (NASDAQ: SEPN ), a biotechnology company focused on G protein-coupled receptor (GPCR) drug discovery, saw its shares fall 4.3% after reporting a widened net loss for ...